Researchers from the Monash Milk Team have published a new study demonstrating the power of human milk as a highly effective ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

PureTech Founded Entity Seaport Therapeutics Announces Publication of New Research Demonstrating Increased Lymphatic Transport with Glyph Platform ...

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...

BOSTON - Seaport Therapeutics, a clinical-stage biopharmaceutical company, has published new research demonstrating significant advancements in drug delivery through the lymphatic system using its ...

The University of Utah is in danger of losing an estimated $50 million in medical research grant dollars a year because of a ...

Ocean Biomedical, Inc. OCEA gained 86% to $0.2751 in pre-market trading. Ocean Biomedical shares gained 11% on Monday after the company announced newly published research findings demonstrating the ...

EST NLS Pharmaceutics (NLSP) files $75M mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...

ZURICH and NESS ZIONA, Israel - NLS Pharmaceutics Ltd. (Nasdaq: NLSP) and Kadimastem Ltd. (TASE: KDST) announced plans for a merger, aiming to enhance diabetes treatment by combining their expertise ...

NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous ...

Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.